Given that hPEBP4 is anti-apoptotic [15]–[17], [19] and that it is highly expressed in human lymphoma cancer tissue, we questioned whether hPEBP4 plays a role in rituximab activity against lymphoma. Here, PEBP4 is linked to lymphoma.